Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003/05/01 by W S Lim, Wei Shen Lim · 3,158 citations
Medicine · #Chronic Disease Management Strategies #Cohort #Cohort study #Community-acquired pneumonia #Disease #Framingham Risk Score #Internal medicine #Logistic regression #Medicine #Nosocomial Infections in ICU #Pneumonia #Pneumonia and Respiratory Infections #Pneumonia severity index #Prospective cohort study
paper · pdf · doi:10.1136/thorax.58.5.377
published in Thorax 58(5), 377-382 (BMJ)
openalex publication_date 2003/05/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Abstract
BACKGROUND: In the assessment of severity in community acquired pneumonia (CAP), the modified British Thoracic Society (mBTS) rule identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with CAP into different management groups. METHODS: Data from three prospective studies of CAP conducted in the UK, New Zealand, and the Netherlands were combined. A derivation cohort comprising 80% of the data was used to develop the model. Prognostic variables were identified using multiple logistic regression with 30 day mortality as the outcome measure. The final model was tested against the validation cohort. RESULTS: 1068 patients were studied (mean age 64 years, 51.5% male, 30 day mortality 9%). Age >/=65 years (OR 3.5, 95% CI 1.6 to 8.0) and albumin <30 g/dl (OR 4.7, 95% CI 2.5 to 8.7) were independently associated with mortality over and above the mBTS rule (OR 5.2, 95% CI 2.7 to 10). A six point score, one point for each of Confusion, Urea >7 mmol/l, Respiratory rate >/=30/min, low systolic(<90 mm Hg) or diastolic (</=60 mm Hg) Blood pressure), age >/=65 years (CURB-65 score) based on information available at initial hospital assessment, enabled patients to be stratified according to increasing risk of mortality: score 0, 0.7%; score 1, 3.2%; score 2, 3%; score 3, 17%; score 4, 41.5% and score 5, 57%. The validation cohort confirmed a similar pattern. CONCLUSIONS: A simple six point score based on confusion, urea, respiratory rate, blood pressure, and age can be used to stratify patients with CAP into different management groups.
Citations
Cited by
- BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability
- Automatic Construction of Clinical Scoring Systems with LLM Agents
- Scalable Stewardship of an LLM-Assisted Clinical Benchmark with Physician Oversight
- Are Mortality and Acute Morbidity in Patients Presenting With Nonspecific Complaints Predictable Using Routine Variables?
- Predicting Mortality with Deep Learning: Are Metrics Alone Enough?
- Derivation and validation of a point-based forecasting tool for SARS-CoV-2 critical care occupancy: a population-based modeling study
- Validation of CURB-65, CRB-65, NEWS2, qSOFA, and 4C scores for predicting mortality in COVID-19 patients across seven emergency Departments in Colombia
- Association Between Elevated Neutrophil-to-Lymphocyte Ratio and Mortality Risk in Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
- Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
- Predicting Mortality Risk in Viral and Unspecified Pneumonia to Assist Clinicians with COVID-19 ECMO Planning
- Compliance with the national and WHO antibiotic treatment guidelines for respiratory tract infections and their association with clinical and economic outcomes in Vietnam: an observational study
- 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia
- A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
- Guidelines for the management of adult lower respiratory tract infections - Full version
- Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool
- Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials
- Exhaled Air Dispersion During Oxygen Delivery Via a Simple Oxygen Mask
- Development and Validation of a Deep Learning Model for Prediction of Severe Outcomes in Suspected COVID-19 Infection
- Community-acquired pneumonia. [europepmc]
- Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. [europepmc]
- Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. [europepmc]
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. [europepmc]
- Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. [europepmc]
- Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. [europepmc]
- The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. [europepmc]
- Guidelines for the management of adult lower respiratory tract infections--full version. [europepmc]
- Community-acquired pneumonia. [europepmc]
- Prediction of In-hospital Mortality in Emergency Department Patients With Sepsis: A Local Big Data-Driven, Machine Learning Approach. [europepmc]
- Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes. [europepmc]
- Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. [europepmc]
- Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. [europepmc]
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. [europepmc]
- Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. [europepmc]
- Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. [europepmc]
- Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19. [europepmc]
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. [europepmc]
- Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. [europepmc]
- "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study". [europepmc]
- Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. [europepmc]
- Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. [europepmc]
- Development and Validation of the Quick COVID-19 Severity Index: A Prognostic Tool for Early Clinical Decompensation. [europepmc]
- The Importance of Respiratory Rate Monitoring: From Healthcare to Sport and Exercise. [europepmc]
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. [europepmc]
Related